Higher CSF/serum free‐T4 ratio is associated with improvement of quality of life during treatment with L‐thyroxine.

MLA

Funkquist, Anders, et al. “Higher CSF/Serum Free‐T4 Ratio Is Associated with Improvement of Quality of Life during Treatment with L‐thyroxine.” Journal of Neuroendocrinology, vol. 35, no. 5, May 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1111/jne.13272.

APA

Funkquist, A., Wandt, B., Blennow, K., Zetterberg, H., Svensson, J., Bjellerup, P., Freund, L. Y., & Sjöberg, S. (2023). Higher CSF/serum free‐T4 ratio is associated with improvement of quality of life during treatment with L‐thyroxine. Journal of Neuroendocrinology, 35(5), 1–11. https://doi.org/10.1111/jne.13272

Chicago

Funkquist, Anders, Birger Wandt, Kaj Blennow, Henrik Zetterberg, Johan Svensson, Per Bjellerup, Levi, Yvonne Freund, and Stefan Sjöberg. 2023. “Higher CSF/Serum Free‐T4 Ratio Is Associated with Improvement of Quality of Life during Treatment with L‐thyroxine.” Journal of Neuroendocrinology 35 (5): 1–11. doi:10.1111/jne.13272.